Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

NIH Grant for Texas Biomed to Perform Mass Spec-Based Studies into Heart Disease

Published: Wednesday, August 20, 2014
Last Updated: Wednesday, August 20, 2014
Bookmark and Share
Institute awarded $2.7M grant from the NIH to fund innovative approaches to genetics research for the development of new therapies for heart disease and other conditions.

The research builds on genetic studies conducted over the past decade by scientists around the world and at Texas Biomed that have helped identify large numbers of differences in the sequence of the human genome that are contributing to a wide range of diseases.  The challenge that remains is understanding how these changes in the DNA sequence specifically affect the cells in the body, and lead to obesity, diabetes, heart disease or even neurological disorders such as Parkinson’s disease. Once scientists understand the underlying mechanisms, they may be able to develop new therapies and actually improve treatment for these diseases.

To accelerate this process, the National Institute for General Medical Sciences (NIGMS) of the National Institutes of Health requested proposals from researchers to develop novel and innovative approaches that will help decipher the function of these specific genome sequence changes, and now awarded Michael Olivier, Ph.D., Texas Biomed’s newest recruit to the Department of Genetics, a new 4-year grant to develop and implement such technologies. His laboratory specifically focuses on developing new ways to study how proteins – little machines in cells that do everything, from producing energy to sending signals to other cells to recognizing and responding to challenges such as fat in the diet – interact with the DNA in our cells to regulate the expression of genes.

Genes can be turned on or off, depending on whether a cell needs more or less of a specific protein, and this complex regulation is influenced by a large number of other proteins that bind to the DNA and regulate it. These regulatory proteins bind to specific sequences in the DNA, and if this sequence is changed in an individual, that particular protein may no longer bind as efficiently. The result is that a nearby gene is regulated differently in a person with this specific change in the DNA sequence.

“Obviously, this complex regulation of genes requires a large number of different proteins, and many of them we do not even know yet,” Olivier said. “This is why we are trying to develop a method that allows us to look at one specific piece of DNA, such as one gene, and to identify all the proteins that are bound to that particular sequence.”

Once the sequence has been isolated, the bound proteins can be identified by mass spectrometry. In collaboration with Joanne Curran, Ph.D., Harald Göring, Ph.D., and John Blangero, Ph.D., in the Texas Biomed Department of Genetics, and Dr. Lloyd Smith, Professor of Chemistry and Director of the Wisconsin Genome Center at the University of Wisconsin, Madison, Dr. Olivier will exploit this new methodology to examine cells from members of the San Antonio Family Study. Here, they will identify proteins that regulate genes important in the regulation of cholesterol and other risk factors for heart disease.

Previous studies have helped identify changes in the DNA sequence of study participants that raise their cholesterol levels, which increases their risk for heart attacks or strokes. This new study will now identify how these sequence changes modify the regulation of specific genes, and which proteins are important in that regulation.

“Identifying the proteins that are important for this regulation of genes will not only help us understand how these sequence changes lead to higher cholesterol levels in these participants, it will also help us to identify new drugs that may help correct these changes, and help reduce the risk for a heart attack or stroke,” Olivier said.

For now, however, his lab is focusing on developing the necessary protocols and methods so that they can begin these investigations – a challenging effort requiring a wide range of expertise in his group, from chemistry to genetics to cell and molecular biology. And with the new support from the NIH, they hope to be able to develop and apply these new methodologies quickly so that they can be used to help understand how the human genome works, and how the sequence differences in it affect disease risk.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Gene Editing Corrects Sickle Cell Mutation
Researchers demonstrate a potential pathway to developing gene-editing treatments for sickle cell disease.
Wednesday, October 26, 2016
Sustained SIV Remission Achieved in Monkeys
Experimental treatment boosts monkey immune system to force SIV into sustained remission.
Wednesday, October 26, 2016
Skin patch to treat peanut allergy shows benefit in children
NIH-funded study suggests patch is safe, convenient mode of treatment.
Wednesday, October 26, 2016
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Friday, October 21, 2016
NIH Study Determines Key Differences between Allergic and Non-Allergic Dust Mite Proteins
Researchers at NIH have uncovered factors that lead to the development of dust mite allergy and assist in the design of better allergy therapies.
Thursday, October 20, 2016
NIH Contributes to Global Effort to Prevent and Manage Lung Diseases
The large scale trial will measure health benefits of clean cookstoves.
Thursday, October 20, 2016
Untangling Cause Of Memory Loss In Neurodegenerative Diseases
NIH-funded mouse study identifies a possible therapeutic target for a family of disorders.
Tuesday, October 18, 2016
NIH Scientists Uncover Genetic Explanation for Frustrating Syndrome
Researchers at NIH have suggested that the multiple alpha tryptase gene copies might underlie health issues that affect a substantial number of people.
Tuesday, October 18, 2016
Scientists at NIH and Emory Achieve Sustained SIV Remission in Monkeys
The finding suggest that the immune systems of these animals are controlling SIV replication in the absence of antiretroviral therapy.
Friday, October 14, 2016
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
Thursday, October 13, 2016
Visual Cortex Plays Role in Plasticity of Eye Movement Reflex
Researchers at NIH have found that the visual cortex region of the brain known to process sensory information plays a vital role in promoting the plasticity of innate, spontaneous eye movements.
Thursday, October 13, 2016
NIH Commits $6.7 M to Advance DNA, RNA Sequencing Technology
"Can you believe they make DNA sequencers the size of staplers?" asked Meni Wanunu, Ph.D. "Ideas that were crazy twenty years ago are now happening!"
Friday, October 07, 2016
Cone Snail Venom Reveals Insulin Insights
Researchers found that a fast-acting insulin from the cone snail can bind and activate the human insulin receptor.
Wednesday, October 05, 2016
DNA Vaccines Protect Monkeys Against Zika Virus
Two experimental Zika virus DNA vaccines developed by NIH scientists protected monkeys against Zika infection.
Wednesday, October 05, 2016
Targeting Cardiovascular Disease Risk Factors May be Important Across a Lifetime
The study suggests efforts to prevent risk factors should extend to those older than 65.
Tuesday, October 04, 2016
Scientific News
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Editing Gene Mutations in Anemia
Researchers successfully use a new gene editing strategy to correct mutations that cause a form of anemia.
Genes Help Track Odd Migrations of Zika Mosquitoes
Study shows that mosquitoes carrying Zika virus or Dengue fever a genetically distinct around the world.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
Gene Editing Corrects Sickle Cell Mutation
Researchers demonstrate a potential pathway to developing gene-editing treatments for sickle cell disease.
Driving Mosquito Evolution to Fight Malaria
Researchers propose insect repellent in conjunction with insecticides to extend current insecticide lifetime.
Lab-on-a-Chip to Help Detect Cancer
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos